These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1674204)

  • 1. Molecular genetics and human prostatic carcinoma.
    Collins VP; Kunimi K; Bergerheim U; Ekman P
    Acta Oncol; 1991; 30(2):181-5. PubMed ID: 1674204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recessive genetic mechanisms in the oncogenesis of prostatic carcinoma.
    Bergerheim US; Collins VP; Ekman P; Kunimi K
    Scand J Urol Nephrol Suppl; 1991; 138():93-6. PubMed ID: 1686123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic loss of chromosomes 16q and 10q in human prostate cancer.
    Carter BS; Ewing CM; Ward WS; Treiger BF; Aalders TW; Schalken JA; Epstein JI; Isaacs WB
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8751-5. PubMed ID: 1978938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma.
    Brewster SF; Browne S; Brown KW
    J Urol; 1994 Apr; 151(4):1073-7. PubMed ID: 7510345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.
    Ittmann MM
    Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma.
    Bergerheim US; Kunimi K; Collins VP; Ekman P
    Genes Chromosomes Cancer; 1991 May; 3(3):215-20. PubMed ID: 1868037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic alterations in localized cancers of the prostate: identification of a common region of deletion on the chromosome 18q].
    Latil A; Baron JC; Cussenot O; Fournier G; Soussi T; Boccon-Gibod L; Le Duc A; Rouëssé J; Lidereau R
    Bull Cancer; 1995 Jul; 82(7):589-97. PubMed ID: 7549122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
    Gao X; Porter AT; Honn KV
    Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma.
    Morita R; Saito S; Ishikawa J; Ogawa O; Yoshida O; Yamakawa K; Nakamura Y
    Cancer Res; 1991 Nov; 51(21):5817-20. PubMed ID: 1682036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity of the retinoblastoma and adenomatous polyposis susceptibility gene loci and in chromosomes 10p, 10q and 16q in human prostate cancer.
    Phillips SM; Morton DG; Lee SJ; Wallace DM; Neoptolemos JP
    Br J Urol; 1994 Apr; 73(4):390-5. PubMed ID: 7911059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelotype study of primary hepatocellular carcinoma.
    Fujimori M; Tokino T; Hino O; Kitagawa T; Imamura T; Okamoto E; Mitsunobu M; Ishikawa T; Nakagama H; Harada H
    Cancer Res; 1991 Jan; 51(1):89-93. PubMed ID: 1670995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma.
    Sun CQ; Arnold R; Fernandez-Golarz C; Parrish AB; Almekinder T; He J; Ho SM; Svoboda P; Pohl J; Marshall FF; Petros JA
    Cancer Res; 2006 Sep; 66(17):8542-9. PubMed ID: 16951166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of the chromosomal region 10q23-25 in prostate cancer.
    Gray IC; Phillips SM; Lee SJ; Neoptolemos JP; Weissenbach J; Spurr NK
    Cancer Res; 1995 Nov; 55(21):4800-3. PubMed ID: 7585509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic changes associated with prostate cancer in humans.
    Isaacs WB; Carter BS
    Cancer Surv; 1991; 11():15-24. PubMed ID: 1841750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas.
    Slagle BL; Zhou YZ; Butel JS
    Cancer Res; 1991 Jan; 51(1):49-54. PubMed ID: 1670994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer.
    Li X; Lee NK; Ye YW; Waber PG; Schweitzer C; Cheng QC; Nisen PD
    J Natl Cancer Inst; 1994 Oct; 86(20):1524-9. PubMed ID: 7932807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P53 mutations and loss of heterozygosity on chromosomes 8p, 16q, 17p, and 18q are confined to advanced prostate cancer.
    Massenkeil G; Oberhuber H; Hailemariam S; Sulser T; Diener PA; Bannwart F; Schäfer R; Schwarte-Waldhoff I
    Anticancer Res; 1994; 14(6B):2785-90. PubMed ID: 7872719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer.
    Trapman J; Sleddens HF; van der Weiden MM; Dinjens WN; Konig JJ; Schroder FH; Faber PW; Bosman FT
    Cancer Res; 1994 Dec; 54(23):6061-4. PubMed ID: 7954446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastasis suppressor genes for prostate cancer.
    Ichikawa T; Nihei N; Kuramochi H; Kawana Y; Killary AM; Rinker-SchaefferCW ; Barrett JC; Isaacs JT; Kugoh H; Oshimura M; Shimazaki J
    Prostate Suppl; 1996; 6():31-5. PubMed ID: 8630227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Putative tumor-suppressor gene on chromosome 11 is important in sporadic endocrine tumor formation.
    Eubanks PJ; Sawicki MP; Samara GJ; Gatti R; Nakamura Y; Tsao D; Johnson C; Hurwitz M; Wan YJ; Passaro E
    Am J Surg; 1994 Jan; 167(1):180-5. PubMed ID: 7906100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.